Acellular Preparation Of Polynucleotide Patents (Class 435/91.5)
-
Publication number: 20130116417Abstract: Described herein are oligosaccharide-oligonucleotide conjugates useful as vaccines against one or more human or veterinary therapeutic indications, and methods of synthesizing and identifying them. The conjugates may be identified using non-human antibodies as binding targets, thereby expanding the power and scope of the invention. Efficacious conjugates may be identified through an iterative.Type: ApplicationFiled: June 10, 2011Publication date: May 9, 2013Applicant: BRANDEIS UNIVERSITYInventors: Isaac J. Krauss, Lizbeth K. Hedstrom, Iain S. MacPherson
-
Publication number: 20130102034Abstract: The present disclosure provides modified nucleosides, nucleotides, and nucleic acids, and methods of using thereof.Type: ApplicationFiled: May 25, 2012Publication date: April 25, 2013Inventor: Jason P. Schrum
-
Publication number: 20130082722Abstract: The present invention relates to a method of forming a nanopore and a structure formed with the nanopore. The present invention relates to a method of forming a nanopore by preparing a first structure and a second structure having a surface on which nucleotides can be attached; attaching one ends of a plurality of oligonucleotides complementary to each other on the surface; binding the first structure and the second structure; and removing some of the bound oligonucleotides. The present invention is effective in that a pore of a desired size can be accurately formed by adjusting the length of the oligonucleotides.Type: ApplicationFiled: September 25, 2012Publication date: April 4, 2013Applicant: LG ELECTRONICS INC.Inventor: LG ELECTRONICS INC.
-
Publication number: 20130085073Abstract: A reaction mixture including (a) a nucleic acid having a primer hybridized to a template, (b) nucleotide analogs, wherein the nucleotide analogs have a blocking moiety; (c) a polymerase that is capable of forming an extended primer by adding the nucleotide analogs to the primer, and (d) a deblocking agent that is capable of removing the blocking moiety from the extended primer. Also provided is a method of synthesizing a polynucleotide including sequentially adding a plurality of the different nucleotides analogs to the nucleic acid via several reaction cycles in the reaction mixture, wherein each reaction cycle includes (i) the polymerase adding a nucleotide analog to the nucleic acid to form a transient nucleic acid species comprising a blocking moiety, and (ii) the deblocking agent modifying the transient nucleic acid species to remove the blocking moiety.Type: ApplicationFiled: September 26, 2012Publication date: April 4, 2013Applicant: ILLUMINA CAMBRIDGE LIMITEDInventor: Illumina Cambridge Limited
-
Publication number: 20130079251Abstract: Systems and methods for processing fluid samples are disclosed. Fluid sample processing is accomplished using a series of microfluidic bump arrays include an automated and integrated system for sorting particles from a biological sample, lysing those particles to expose total RNA or DNA, purifying the RNA or DNA, processing the RNA or DNA by chemical or enzymatic modification, to select RNA or DNA molecules by size, or to generate, optionally, a sequencing library. The sequencing library is suitable for use in next generation sequencing (“NGS”).Type: ApplicationFiled: August 3, 2012Publication date: March 28, 2013Applicant: Sage Science, Inc.Inventor: T. Christian Boles
-
Publication number: 20130072388Abstract: Provided are novel nucleotides, nucleoside, and their derivatives described herein, that can be used in DNA sequencing technology and other types of DNA analysis. In one embodiment, the nucleotide or nucleoside with an unprotected 3?-OH group is derivatized at the nucleobase to include a fluorescent dye attached via a linker to a photocleavable terminating group. The photocleavable-fluorescent group is designed to terminate DNA synthesis as well as be cleaved so that DNA oligomers can be sequenced efficiently in a parallel format. The design of such rapidly cleavable fluorescent groups on nucleotides and nucleosides can enhance the speed and accuracy of sequencing of large oligomers of DNA in parallel, to allow rapid whole genome sequencing, and the identification of polymorphisms and other valuable genetic information, as well as allowing further manipulation and analysis of nucleic acid molecules in their native state following cleavage of the fluorescent group.Type: ApplicationFiled: August 23, 2012Publication date: March 21, 2013Inventors: Weidong WU, Vladislav A. Litosh, Brian P. Stupi, Michael L. Metzker
-
Publication number: 20130059342Abstract: The present invention relates to compositions and methods for use in recombinational cloning of nucleic acid molecules. In particular, the invention relates to nucleic acid molecules encoding one or more recombination sites or portions thereof, to nucleic acid molecules comprising one or more of these recombination site nucleotide sequences and optionally comprising one or more additional physical or functional nucleotide sequences. The invention also relates to vectors comprising nucleic acid molecules of the invention, to host cells comprising vectors or nucleic acid molecules of the invention, to methods of producing polypeptides using nucleic acid molecules of the invention, and to polypeptides encoded by these nucleic acid molecules or produced by methods of the invention. The invention also relates to the use of these compositions in methods for recombinational cloning of nucleic acids, in vitro and in vivo, to provide chimeric DNA molecules that have particular characteristics and/or DNA segments.Type: ApplicationFiled: June 28, 2012Publication date: March 7, 2013Applicant: LIFE TECHNOLOGIES CORPORATIONInventors: James L. HARTLEY, Michael A. Brasch, Gary F. Temple, David Cheo
-
Publication number: 20130059343Abstract: The present invention provides compounds and methods for attaching fluorescent labels to biological molecules such as nucleotides. The compounds and methods are useful for biological assays including DNA modification reactions.Type: ApplicationFiled: August 8, 2012Publication date: March 7, 2013Applicant: LI-COR, INC.Inventor: Lael Cheung
-
Publication number: 20130059748Abstract: Described herein are primers and probes useful for the binding, detecting, differentiating, isolating, and sequencing of influenza A, influenza B and RSV viruses.Type: ApplicationFiled: July 5, 2012Publication date: March 7, 2013Inventors: James R. Hully, Alice A. Jacobs, Damien Slater, Heather Kiefer, Chesley Leslin, Juan Anzola
-
Publication number: 20130034881Abstract: Demethylation of a methylated DNA sequence in a eukaryotic cell is described, utilising a molecule that includes at least a first domain that exhibits a cytidine deaminase activity and at least a second domain that confers either a specific or non-specific DNA binding activity.Type: ApplicationFiled: October 5, 2012Publication date: February 7, 2013Applicant: CELLCENTRIC LIMITEDInventor: CELLCENTRIC LIMITED
-
Publication number: 20130034880Abstract: Aspects of the invention include methods for improving the accuracy and read length of sequencing reactions by utilizing unlabeled unincorporable nucleotides, or by rephasing colony based sequencing reactions. Other aspects include systems and devices for improved measurement of biological reactions associated with bead which may be removed, utilizing current measurement methods through the counter ions associated with said beads due to the presence of reactants bound or associated with said bead, wherein electrodes for generating and measuring said current may be within the Debye length of said bead. Other aspects of the invention include methods for determining concentrations of input samples, means for reuse of an array, methods and apparatus for separating beads with different charge levels from each other.Type: ApplicationFiled: May 27, 2012Publication date: February 7, 2013Inventor: Mark F. Oldham
-
Publication number: 20130029881Abstract: Methods are provided for adding a terminal sequence tag to nucleic acid molecules for use in RNA or DNA amplification. The tag introduced may be used as a primer binding site for subsequent amplification of the DNA molecule and/or sequencing of the DNA molecule and therefore provides means for identification and cloning of the 5?-end or the complete sequence of mRNAs.Type: ApplicationFiled: September 26, 2012Publication date: January 31, 2013Inventor: Roy R. Sooknanan
-
Publication number: 20130022980Abstract: The present invention is directed to DNA polymerase fusion proteins with increased processivity and nucleic acid affinity. The invention includes a fusion protein comprising a nucleic acid-binding domain fused to a polymerase domain. The nucleic acid binding domain contains at least one nucleic acid binding motif, such as a DNA-binding motif or an RNA-binding motif. The nucleic acid binding domain preferably embodies an oligonucleotide/oligosaccharide binding (OB) fold, among other conformations. The invention further includes methods of synthesizing nucleic acids using the fusion proteins described herein.Type: ApplicationFiled: February 4, 2010Publication date: January 24, 2013Inventors: Robert Michael Nelson, Thomas W. Schoenfeld, David A. Mead
-
Publication number: 20130023009Abstract: Provided is a method for selectively obtaining, for a given target gene, a “joined DNA fragment” wherein just a target gene fragment is joined with desired other DNA fragments, regardless of whether a DNA fragment containing a target gene sequence has been purified. In the provided method, a double-stranded joining DNA fragment containing a sequence A and/or a sequence B is selectively joined to the ends of a target gene fragment. A mixture of a double-stranded gene fragment, the 3? end of which is protruding, and the double-stranded joining DNA fragment, which are related in a prescribed manner, undergoes at least two cycles of thermal denaturation, reassociation, and DNA synthesis, resulting in a “joined DNA fragment,” which is a double-stranded DNA fragment including at least one instance of a sequence resulting from joining sequence A, the target gene sequence, and sequence B. A “single-side joined DNA fragment” can also be obtained, by a similar method.Type: ApplicationFiled: September 2, 2010Publication date: January 24, 2013Applicant: NATIONAL UNIVERSITY CORPORATION UNIVERSITY OF TOYAMAInventors: Nobuyuki Kurosawa, Masaharu Isobe
-
Publication number: 20130017578Abstract: The present invention refers to muteins of the bacteriophage lambda integrases and to nucleic acid molecules comprising a nucleotide sequence encoding such muteins of the lambda integrases. The invention further refers to host cells containing a nucleic acid molecule comprising a nucleotide sequence encoding such muteins of the lambda integrases. The invention also refers to methods of recombining nucleic acids of interest into target nucleic acids in the presence of the muteins of the lambda integrases, as well as sequence specific recombination kits.Type: ApplicationFiled: November 8, 2010Publication date: January 17, 2013Inventors: Farid John Ghadessy, Mei Sian Yvonne Tay, Peter Drodge
-
Publication number: 20130005612Abstract: A method for synthesizing a nucleic acid having a desired sequence and length comprises providing a solid support having an immobilized nucleic acid, performing a nucleic acid addition reaction to elongate the immobilized nucleic acid by adding a nucleotide or an oligonucleotide attached to a protecting group to the nucleic acid, determining whether the nucleotide or the oligonucleotide is added to the nucleic acid, removing the protecting group, and continuing until the immobilized nucleic acid has a desired sequence and length.Type: ApplicationFiled: September 11, 2012Publication date: January 3, 2013Applicant: MASSACHUSETTS INSTITUTE OF TECHNOLOGYInventors: Peter A. Carr, Brian Y. Chow, Joseph M. Jacobson, David W. Mosley, Christopher Emig
-
Publication number: 20130005581Abstract: Disclosed is a composition comprising the nucleic acid and a chemical compound, said composition forming a star structure defining 3 or more stems extending from a reaction center. The stems are formed by a nucleic acid duplex and the chemical compound has been formed in the reaction center as the reaction product of 3 or more chemical groups. The advantage of the composition is that a close proximity is provided between the chemical groups in the reaction center, thereby promoting a reaction. The invention also relates to a method for preparation of the composition. The advantage of the method is that it does not require the pre-synthesis of a large number of templates and that it is not dependent upon codon/anti-codon recognition for an encoded molecule to be formed.Type: ApplicationFiled: May 17, 2012Publication date: January 3, 2013Applicant: VIPERGEN APSInventors: Nils Jokob Vest Hansen, Peter Blakskjaer, Margit Haahr Hansen, Lars Kolster Petersen, Tara Renee Heitner
-
Publication number: 20130004996Abstract: The present invention provides compositions and methods for recombinational cloning. The compositions include vectors having multiple recombination sites and/or multiple topoisomerase recognition sites. The methods permit the simultaneous cloning of two or more different nucleic acid molecules. In some embodiments the molecules are fused together while in other embodiments the molecules are inserted into distinct sites in a vector. The invention also generally provides for linking or joining through recombination a number of molecules and/or compounds (e.g., chemical compounds, drugs, proteins or peptides, lipids, nucleic acids, carbohydrates, etc.) which may be the same or different.Type: ApplicationFiled: August 26, 2011Publication date: January 3, 2013Applicant: LIFE TECHNOLOGIES CORPORATIONInventors: Jonathan D. CHESNUT, John Carrino, Louis Leong, Knut Madden, Martin A. G. Gleeson, James Fan, Michael A. Brasch, David Cheo, James L. Hartley, Devon R.N. Byrd, Gary F. Temple
-
Publication number: 20120329667Abstract: This application relates to methods for enriching DNA from a first cell type from a sample comprising DNA from the first cell type and DNA from a second cell type, wherein the first cell type methylates DNA to a lesser extent than the second cell type. DNA is enriched by, selecting for fragments by size after digestion of the sample with a methylation-sensitive restriction enzyme. Cell types of interest include fetal cells and cancerous cells. The enriched DNA can be used for a variety of procedures including, detection of a trait of interest such as a disease trait, or a genetic predisposition thereto, gender typing and parentage testing.Type: ApplicationFiled: October 13, 2010Publication date: December 27, 2012Applicant: GENETIC TECHNOLOGIES LIMITEDInventors: Richard Allman, Eduardo Vom, Craig Matthew Lewis, Debbie Mantzaris, Stuart Cantsilieris
-
Publication number: 20120322057Abstract: Disclosed herein are modified polymerase compositions exhibiting altered polymerase activity, which can be useful in a variety of biological applications. Also disclosed herein are methods of making and using such compositions. In some embodiments, the compositions exhibit altered properties that can enhance their utility in a variety of biological applications. Such altered properties, can include, for example, altered nucleotide binding affinities, altered nucleotide incorporation kinetics, altered photostability and/or altered nanoparticle tolerance, as well as a range of other properties as disclosed herein.Type: ApplicationFiled: July 3, 2012Publication date: December 20, 2012Applicant: LIFE TECHNOLOGIES CORPORATIONInventors: Stephen P. HENDRICKS, Michael PHELAN, Marian PERIS, Cheng-Yao CHEN, Daniel MAZUR, Xinzhan PENG, Amy CASTILLO
-
Publication number: 20120322109Abstract: The present invention provides a method of covalently joining a DNA strand to an RNA strand, a method of tagging a 5? end of an RNA molecule, a DNA-RNA molecule which has been joined in vitro by the use of a topoisomerase, a method of tagging a 5? end of an mRNA, and a method of isolating and cloning full-length gene sequences using capped mRNA after subtraction of non-capped RNA.Type: ApplicationFiled: April 30, 2012Publication date: December 20, 2012Inventors: STEWART SHUMAN, JOANN SEKIGUCHI, JOHN COMISKEY, JOSEPH FERNANDEZ, JAMES HOEFFLER, ROBERT MARCIL
-
Publication number: 20120322066Abstract: This disclosure relates to novel detergents for use in various procedures including, for example, nucleic acid amplification reactions such as polymerase chain reaction (PCR). Methods for preparing the modified detergents are also described.Type: ApplicationFiled: June 8, 2012Publication date: December 20, 2012Applicant: Life Technologies CorporationInventors: Parul Angrish, Zhiwei Yang, Jonathan Wang
-
Publication number: 20120322666Abstract: Compositions, methods and systems are provided for the isolation of polymerase-nucleic acid complexes. Complexes can be separated from free enzyme by using hook molecules to target single stranded regions on the nucleic acid. Active complexes can be isolated from mixtures having both active and inactive complexes by initiating nucleic acid synthesis so as to open up a portion of a double stranded region rendering that region single stranded. Hook molecules are targeted to bind the sequences that are thus exposed. The hook molecules bound to active polymerase-nucleic acid complex are isolated, and the active polymerase-nucleic acid complexes released.Type: ApplicationFiled: March 22, 2012Publication date: December 20, 2012Applicant: Pacific Biosciences of California, Inc.Inventors: Thang Pham, Arunashree Bhamidipati, Kevin Travers, Eric Olivares, Tyson A. Clark, Jonas Korlach
-
Patent number: 8323930Abstract: Provided are methods, compositions, and kits for molecular cloning of DNA using DNA topoisomerase. The methods comprise (I) combining into a mixture (A) a first polynucleotide, comprising an origin of replication, a selectable marker, two topoisomerase recognition sequences, and two nicking agent recognition sequences, each of the topoisomerase recognition sequences being within 50 nucleotides of at least one of the nicking agent recognition sequences and each of two nicking agent recognition sequences being nicked, with (B) a sequence-specific topoisomerase and (C) a second polynucleotide, having a 5? hydroxyl on each end; and (II) transforming the mixture into a host organism, thereby cloning the second polynucleotide. Formation or purification of a DNA-protein adduct prior to the addition of the second polynucleotide is not required. Also provided are vector sequences to facilitate performance of the methods and methods for modifying a vector of interest to render it useful in the disclosed methods.Type: GrantFiled: July 23, 2008Date of Patent: December 4, 2012Assignee: DNA Twopointo, Inc.Inventors: Jon E. Ness, Jeremy S. Minshull
-
Publication number: 20120301926Abstract: In some embodiments, the present teachings provide compositions, systems, methods and kits for generating a population of nucleic acid fragments. In some embodiments, nucleic acids can be fragmented enzymatically. For example, methods for generating a population of nucleic acid fragments can include a nucleic acid nicking reaction. In one embodiment, the methods can include a nick translation reaction. A nicking reaction can introduce nicks at random positions on either strand of a double-stranded nucleic acid. A nick translation reaction can move the position of nicks to a new position so that the new positions of two of the nicks are aligned to create a double-stranded break. In some embodiments, methods for generating a population of nucleic acid fragments can include joining at least one end of a fragmented nucleic acid to one or more oligonucleotide adaptors.Type: ApplicationFiled: May 29, 2012Publication date: November 29, 2012Applicant: LIFE TECHNOLOGIES CORPORATIONInventors: Zhoutao CHEN, Xiaoping DUAN, Kyusung PARK
-
Publication number: 20120301925Abstract: The present invention provides new compositions for transposase-mediated fragmenting and tagging DNA targets. The invention relates to the surprising discovery that use of manganese ions (Mn2+) in transposase reactions improves the transposase reaction. It also relates to the surprising discovery that Mg2+ ions can be used in a transposase reaction with wild-type and/or engineered transposases at levels much higher than previously thought. The invention provides for the use of naturally-occurring transposases in in vitro reactions, as well as improved schemes for cleaving, tagging, and amplifying target DNA.Type: ApplicationFiled: May 11, 2012Publication date: November 29, 2012Inventor: Alexander S Belyaev
-
Publication number: 20120283425Abstract: The invention is directed to isolated genomic polynucleotide fragments that encode human lipoprotein-associated phospholipase A2, vectors and hosts containing the fragment and fragments hybridizing to noncoding regions as well as antisense oligonucleotides to these fragments. The invention is further directed to methods of using these fragments to obtain human lipoprotein-associated phospholipase A2 and to diagnose, treat, prevent and/or ameliorate a pathological disorder.Type: ApplicationFiled: July 23, 2012Publication date: November 8, 2012Applicant: RYOGEN LLCInventor: James W. Ryan
-
Publication number: 20120263783Abstract: The present technology relates to a nanoparticle platform based on the unique and varied properties of DNA. Circular DNA can be replicated using a strand displacing polymerase to generate long linear concatamers of controllable length that spontaneously fold into a ball conformation due to internal base-pairing. These balls of DNA are discreet particles that can be made in variable sizes on a nanometer size scale in a scalable manner. The particles can be used in a variety of manners, discussed herein, including specific targeting, drug delivery to cancer cells, and diagnostics. Nanoparticles may also serve as multifunctional platforms for the integration of many currently used cancer therapeutic techniques.Type: ApplicationFiled: October 19, 2010Publication date: October 18, 2012Applicant: THE REGENTS OF THE UNIVERSITY OF CALIFORNIAInventor: Bradley T. Messmer
-
Publication number: 20120266328Abstract: The invention is directed to polypeptides having any cellulolytic activity, e.g., a cellulase activity, e.g., endoglucanase, cellobiohydrolase, beta-glucosidase, xylanase, mannanse, ?-xylosidase, arabinofuranosidase, and/or oligomerase activity, including thermostable and thermotolerant activity, and polynucleotides encoding these enzymes, and making and using these polynucleotides and polypeptides. The polypeptides of the invention can be used in a variety of pharmaceutical, agricultural, food and feed processing and industrial contexts. The invention also provides compositions or products of manufacture comprising mixtures of enzymes comprising at least one enzyme of this invention.Type: ApplicationFiled: January 20, 2012Publication date: October 18, 2012Applicant: BP CORPORATION NORTH AMERICA INC.Inventors: KEVIN A. GRAY, LISHAN ZHAO, MICHELLE H. CAYOUETTE
-
Publication number: 20120258499Abstract: The present invention features novel, diverse, hybrid and engineered recombinase enzymes, and the utility of such proteins with associated recombination factors for carrying out DNA amplification assays. The present invention also features different recombinase ‘systems’ having distinct biochemical activities in DNA amplification assays, and differing requirements for loading factors, single-stranded DNA binding proteins (SSBs), and the quantity of crowding agent employed.Type: ApplicationFiled: November 30, 2011Publication date: October 11, 2012Applicant: ALERE SAN DIEGO, INC.Inventors: Olaf Piepenburg, Niall A. Armes, Mathew James David Parker
-
Publication number: 20120258487Abstract: This invention provides methods and compositions for assembling biological constructs (e.g., plasmids, transformed cells, etc.). In certain embodiments the methods involve encapsulating separate components of said biological construct each in a fluid droplet confined in a fluid channel; optionally mixing droplets from different fluid channels to for a sequenced order of droplets carrying different components of said biological construct in a channel or chamber; and optionally combining two or more droplets each containing different components of said biological construct to permit said components to react with each other in one or more reactions contributing to the assembly of said biological construct.Type: ApplicationFiled: April 2, 2012Publication date: October 11, 2012Applicants: THE REGENTS OF THE UNIVERSITY OF CALIFORNIA, SANDIA CORPORATIONInventors: Chieh Chang, Rajiv Bharadwaj, Anup K. Singh, Aarthi Chandrasekaran, Nathan J. Hillson
-
Publication number: 20120258501Abstract: Disclosed are DNA polymerases having increased reverse transcriptase efficiency, mismatch tolerance, extension rate and/or tolerance of RT and polymerase inhibitors relative to a corresponding, unmodified polymerase. The polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the DNA polymerases.Type: ApplicationFiled: April 10, 2012Publication date: October 11, 2012Applicant: Roche Molecular Systems, Inc.Inventors: Keith Bauer, Thomas Myers, Fred Reichert, Joseph San Filippo, Rachel Shahinian, Shawn Suko
-
Publication number: 20120252072Abstract: The present invention relates to the discovery of a novel restriction/modification system in Caldicellulosiruptor bescii. The discovered restriction enzyme is a HaeIII-like restriction enzyme that possesses a thermophilic activity profile. The restriction/modification system also includes a methyltransferase, M.CbeI, that methylates at least one cytosine residue in the CbeI recognition sequence to m4C. Thus, the invention provides, in various aspects, isolated CbeI or M.CbeI polypeptides, or biologically active fragments thereof; isolated polynucleotides that encode the CbeI or M.CbeI polypeptides or biologically active fragments thereof, including expression vectors that include such polynucleotide sequences; methods of digesting DNA using a CbeI polypeptide; methods of treating a DNA molecule using a M.CbeI polypeptide; and methods of transforming a Caldicellulosiruptor cell.Type: ApplicationFiled: April 4, 2012Publication date: October 4, 2012Inventors: JANET WESTPHELING, DaeHwan Chung, Jennifer Huddleston, Joel A. Farkas
-
Publication number: 20120244535Abstract: 3-alkynyl inosine analogs and their uses as universal bases are provided. The inosine analogues can be incorporated into nucleic acid primers and probes. They do not significantly destabilize nucleic acid duplexes. As a result, the novel nucleic acid primers and probes incorporating the inosine analogues can be used in a variety of methods. The analogs function unexpectedly well as universal bases. Not only do they stabilize duplexes substantially more than hypoxanthine opposite A, C, T, and G but they are also recognized in primers by polymerases, allowing efficient amplification.Type: ApplicationFiled: March 23, 2012Publication date: September 27, 2012Inventors: Alexei Vorobiev, Eugeny A. Lukhtanov, Noah Scarr
-
Publication number: 20120245340Abstract: The present invention relates to novel unnatural fluorescent nucleic acid bases, that is, a purine base, a 1-deazapurine base, and a 1,7-deazapurine base each having a functional group which consists of two or more heterocyclic moieties linked together, at the 6-position thereof (the 6-position of purine ring). The present invention also relates to a compound containing the unnatural base, a derivative thereof, and a nucleic acid containing a nucleotide having the unnatural base. The present invention also relates to a method of preparing the nucleic acid. The unnatural base of the present invention has excellent fluorescence characteristics and also has excellent properties as a universal base.Type: ApplicationFiled: October 6, 2010Publication date: September 27, 2012Applicants: TAGCYX Biotechnologies, RikenInventors: Ichiro Hirao, Michiko Hirao, Shigeyuki Yokoyama, Tsuneo Mitsui
-
Patent number: 8263332Abstract: A mismatched end DNA ligase is provided, which ligates two single strands to each other at a high efficiency, even if the other two single strands are not compatible. In one embodiment, the polypeptides of the ligase are Ku, Cernunnos, and XRCC4/Ligase4 (XL). This association can ligate DNA ends with a 3? overhang to a recessed 5? end, to a blunt end, or to a compatible end. In another embodiment, the proteins are Ku, Cernunnos, XRCC4/Ligase4 (XL) and DNA-PK.Type: GrantFiled: October 11, 2007Date of Patent: September 11, 2012Assignee: The Board of Trustees of the Leland Stanford Junior UniversityInventors: Chun Tsai, Seonhi Kim, Gilbert Chu
-
Publication number: 20120208239Abstract: Disclosed are mutant DNA polymerases having increased 3?-mismatch discrimination relative to a corresponding, unmodified polymerase. The mutant polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the mutant DNA polymerases.Type: ApplicationFiled: July 11, 2011Publication date: August 16, 2012Applicant: Roche Molecualr Systems, Inc.Inventors: Keith Bauer, Fred Reichert, Thomas W. Myers
-
Publication number: 20120208240Abstract: Disclosed are mutant DNA polymerases having increased 3?-mismatch discrimination relative to a corresponding, unmodified polymerase. The mutant polymerases are useful in a variety of disclosed primer extension methods. Also disclosed are related compositions, including recombinant nucleic acids, vectors, and host cells, which are useful, e.g., for production of the mutant DNA polymerases.Type: ApplicationFiled: July 11, 2011Publication date: August 16, 2012Applicant: Roche Molecurlar Systems, Inc.Inventors: Keith Bauer, Fred Reichert, Thomas W. Myers
-
Publication number: 20120202196Abstract: Nucleosides and nucleotides are disclosed that are linked to detectable labels via a cleavable linker group.Type: ApplicationFiled: March 28, 2012Publication date: August 9, 2012Applicant: Illumina Cambridge LimitedInventors: Shankar Balasubramanian, Colin Barnes, Xiaohai Liu, John Milton
-
Publication number: 20120196329Abstract: This disclosure relates to methods of performing activation by polyphosphorolysis (APP) reactions using at least one of the polyphosphorylating agents triphosphate, polyphosphate, imidodiphosphate, thiodiphosphate (or ?-monothiopyrophosphate), and related compounds.Type: ApplicationFiled: December 13, 2011Publication date: August 2, 2012Applicant: LIFE TECHNOLOGIES CORPORATIONInventors: Lei (Larry) XI, Paul Kenney, Zhaochun Ma, Dennis Prosen, Stephen Hendricks, Roland Nagel
-
Publication number: 20120190014Abstract: A DNA polymerase chimera comprising an amino-terminal (N-terminal) region encoding a ?29 type DNA polymerase and a carboxyl-terminal (C-terminal) region comprising at least one HhH domain which are bound by means of a connecting amino acid sequence is disclosed along with and the use thereof for replicating, amplifying or sequencing a template DNA. Also disclosed is a method for replicating, amplifying or sequencing a deoxyribonucleic acid with said DNA polymerase chimera and kits for carrying out said methods.Type: ApplicationFiled: July 1, 2010Publication date: July 26, 2012Applicant: Consejo Superior De Investigaciones CientificasInventors: Margarita Salas Falgueras, Miguel De Vega Jose, Jose M. Lazaro Bolos, Luis Blanco Davila, Mario Mencia Caballero
-
Publication number: 20120183953Abstract: The invention generally relates to methods for assembling sequence contigs. In certain embodiments, methods of the invention involve converting sequence contigs into maps, generating a plurality of single molecule restriction maps, aligning single molecule restriction maps to ends of the maps of the sequence contigs, thereby producing extended sequence contigs, and aligning extended sequence contigs.Type: ApplicationFiled: April 28, 2011Publication date: July 19, 2012Applicant: OpGen, Inc.Inventors: Nianqing XIAO, John K. HENKHAUS, Bin ZHU, Deacon SWEENEY, Thomas ANANTHARAMAN, Ryan PTASHKIN
-
Publication number: 20120183999Abstract: The present invention provides compositions and methods for recombinational cloning. The compositions include vectors having multiple recombination sites with unique specificity. The methods permit the simultaneous cloning of two or more different nucleic acid molecules. In some embodiments the molecules are fused together while in other embodiments the molecules are inserted into distinct sites in a vector. The invention also generally provides for linking or joining through recombination a number of molecules and/or compounds (e.g., chemical compounds, drugs, proteins or peptides, lipids, nucleic acids, carbohydrates, etc.) which may be the same or different. Such molecules and/or compounds or combinations of such molecules and/or compounds can also be bound through recombination to various structures or supports according to the invention.Type: ApplicationFiled: November 23, 2011Publication date: July 19, 2012Applicant: LIFE TECHNOLOGIES CORPORATIONInventors: David CHEO, Michael A. Brasch, Gary F. Temple, James L. Hartley, Devon R.N. Byrd
-
Publication number: 20120178092Abstract: Methods for replicating, amplifying or sequencing a deoxyribonucleic acid with a ?29 type DNA polymerase are disclosed, along with kits for carrying out the methods.Type: ApplicationFiled: July 2, 2010Publication date: July 12, 2012Applicant: CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICASInventors: Margarita Salas Falgueras, Miguel De Vega Jose, Jose M. Lazaro Bolos, Luis Blanco Davila, Mario Mencia Caballero
-
Publication number: 20120171729Abstract: The present invention provides compositions, kits, and methods for synthesizing polyadenylic acid using polynucleotide phosphorylase, adenosine diphosphate, a buffering agent, and a divalent metal cation. In certain embodiments, the adenosine diphosphate is present at a concentration between about 5.0 mM and about 100 mM, and the buffering agent has a pH around 8.0. In some embodiments, the prepared polyadenylic acid compositions are free of detectable nucleic acid.Type: ApplicationFiled: December 30, 2011Publication date: July 5, 2012Applicant: IBIS BIOSCIENCES, INC.Inventors: Mark W. Eshoo, Curtis Phillipson
-
Publication number: 20120157327Abstract: The present invention relates to methods and reagents for detecting analytes, e.g. nucleic acids. The new methods and reagents allow a simple and sensitive detection even in complex biological samples.Type: ApplicationFiled: March 2, 2012Publication date: June 21, 2012Applicant: BASECLICK GMBHInventors: Thomas CARELL, Anja SCHWÕEGLER, Glenn A. BURLEY, Johannes GIERLICH, Mohammad Reza MOFID
-
Patent number: 8198029Abstract: Provided are novel nucleotides, nucleoside, and their derivatives described herein, that can be used in DNA sequencing technology and other types of DNA analysis. In one embodiment, the nucleotide or nucleoside with an unprotected 3?-OH group is derivatized at the nucleobase to include a fluorescent dye attached via a linker to a non-cleavable terminating group. The non-cleavable-fluorescent group is designed to terminate DNA synthesis so that DNA oligomers can be sequenced efficiently in a parallel format. These reagents and methods will lead to more accurate identification of polymorphisms and other valuable genetic information.Type: GrantFiled: January 7, 2011Date of Patent: June 12, 2012Assignee: Lasergen, IncInventors: Weidong Wu, Vladislav A. Litosh, Brian P. Stupi, Michael L. Metzker
-
Publication number: 20120142061Abstract: A heat labile alkaline phosphatase enzyme and methods of using the same and kits including the same are disclosed. Specifically, a nucleotide sequence of, peptide sequence of, methods of using, and kits comprising, a heat labile alkaline phosphatase isolated from Colwellia psychrerythraea are provided. Methods of over-expression and purification of the recombinant alkaline phosphatase and mutants thereof are also disclosed. Methods of over-expressing and purifying commercially useful quantities of active recombinant heat labile alkaline phosphatase fusion enzymes from C. psychrerythraea, wherein the fusion enzymes comprise one or more heterologous leader sequences are disclosed. The disclosed C. psychrerythraea heat labile alkaline phosphatase has properties similar to shrimp alkaline phosphatase and can be substituted for shrimp alkaline phosphatase in assays involving the same.Type: ApplicationFiled: January 23, 2012Publication date: June 7, 2012Applicant: Affymetrix, Inc.Inventors: Jeannine Muller-Greven, Marc A. Post, Christopher J. Kubu
-
Patent number: 8192932Abstract: The present invention provides a method of covalently joining a DNA strand to an RNA strand, a method of tagging a 5? end of an RNA molecule, a DNA-RNA molecule which has been joined in vitro by the use of a topoisomerase, a method of tagging a 5? end of an mRNA, and a method of isolating and cloning full-length gene sequences using capped mRNA after subtraction of non-capped RNA.Type: GrantFiled: February 12, 2010Date of Patent: June 5, 2012Assignees: Sloan-Kettering Institute For Cancer Research, Invitrogen CorporationInventors: Stewart Shuman, JoAnn Sekiguchi, John Comiskey, Joseph Fernandez, James Hoeffler, Robert Marcil
-
Publication number: 20120129225Abstract: The present invention provides compositions, methods, and kits for covalently linking nucleic acid molecules. The methods include a strand invasion step, and the compositions and kits are useful for performing such methods. For example, a method of covalently linking double stranded (ds) nucleic acid molecules can include contacting a first ds nucleic acid molecule, which has a topoisomerase linked to a 3? terminus of one end and has a single stranded 5? overhang at the same end, with a second ds nucleic acid molecule having a blunt end, such that the 5? overhang can hybridize to a complementary sequence of the blunt end of the second nucleic acid molecule, and the topoisomerase can covalently link the ds nucleic acid molecules. The methods are simpler and more efficient than previous methods for covalently linking nucleic acid sequences.Type: ApplicationFiled: August 8, 2011Publication date: May 24, 2012Applicant: LIFE TECHNOLOGIES CORPORATIONInventors: Jonathan D. Chesnut, Stewart Shuman, Knut R. Madden, John A. Heyman, Robert P. Bennett